A
AceBed
KOSDAQ:003800
AceBed
KOSDAQ:003800
Price:
25 900
KRW
Market Cap:
264.7B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
AceBed
25900
0 (0%)
| 52 Week Range |
24 450
28 000
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
AceBed
Balance Sheet
Balance Sheet Decomposition
AceBed
AceBed
| Current Assets | 158.2B |
| Cash & Short-Term Investments | 101.3B |
| Receivables | 23.9B |
| Other Current Assets | 33B |
| Non-Current Assets | 597.3B |
| Long-Term Investments | 97.6B |
| PP&E | 483.1B |
| Intangibles | 37.9m |
| Other Non-Current Assets | 16.5B |
| Current Liabilities | 66.3B |
| Accounts Payable | 6B |
| Accrued Liabilities | 18.3B |
| Other Current Liabilities | 42B |
| Non-Current Liabilities | 3.4B |
| Long-Term Debt | 605.2m |
| Other Non-Current Liabilities | 2.8B |
Balance Sheet
AceBed
AceBed
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
18 974
|
24 292
|
28 607
|
21 553
|
21 191
|
17 831
|
25 044
|
52 139
|
35 341
|
37 767
|
|
| Cash |
56
|
49
|
66
|
63
|
57
|
83
|
29
|
6
|
1
|
1
|
|
| Cash Equivalents |
18 918
|
24 243
|
28 541
|
21 490
|
21 134
|
17 748
|
25 015
|
52 133
|
35 340
|
37 766
|
|
| Short-Term Investments |
47 724
|
32 212
|
16 823
|
508
|
2 232
|
3 939
|
11 761
|
21 193
|
61 165
|
49 838
|
|
| Total Receivables |
15 175
|
14 567
|
15 848
|
21 024
|
21 141
|
21 405
|
30 560
|
23 997
|
26 960
|
25 130
|
|
| Accounts Receivables |
14 916
|
14 271
|
15 527
|
20 794
|
20 166
|
21 051
|
20 482
|
22 650
|
25 316
|
23 206
|
|
| Other Receivables |
259
|
296
|
321
|
230
|
975
|
354
|
10 078
|
1 347
|
1 643
|
1 923
|
|
| Inventory |
23 202
|
22 880
|
25 671
|
25 561
|
25 679
|
27 422
|
28 771
|
36 180
|
34 795
|
31 161
|
|
| Other Current Assets |
4 416
|
3 387
|
4 101
|
3 448
|
3 251
|
3 463
|
4 147
|
2 013
|
1 532
|
1 416
|
|
| Total Current Assets |
109 490
|
97 338
|
91 051
|
72 095
|
73 494
|
74 061
|
100 284
|
135 522
|
159 793
|
145 312
|
|
| PP&E Net |
179 577
|
207 156
|
238 712
|
263 033
|
309 259
|
349 222
|
388 041
|
393 539
|
430 951
|
479 000
|
|
| PP&E Gross |
179 577
|
207 156
|
238 712
|
263 033
|
309 259
|
349 222
|
388 041
|
393 539
|
430 951
|
479 000
|
|
| Accumulated Depreciation |
65 009
|
69 755
|
74 986
|
79 921
|
80 224
|
86 723
|
91 335
|
95 617
|
103 271
|
111 822
|
|
| Intangible Assets |
1 253
|
1 194
|
1 253
|
1 134
|
241
|
210
|
201
|
46
|
23
|
44
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
5 786
|
5 465
|
4 312
|
4 954
|
|
| Long-Term Investments |
56 001
|
71 179
|
67 105
|
80 300
|
81 582
|
83 942
|
77 239
|
103 199
|
83 262
|
81 278
|
|
| Other Long-Term Assets |
5 334
|
5 396
|
6 562
|
9 333
|
12 530
|
12 252
|
4 394
|
4 793
|
7 159
|
6 076
|
|
| Total Assets |
351 656
N/A
|
382 262
+9%
|
404 682
+6%
|
425 894
+5%
|
477 105
+12%
|
519 688
+9%
|
575 946
+11%
|
642 564
+12%
|
685 499
+7%
|
716 664
+5%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
5 474
|
5 608
|
5 531
|
4 684
|
5 717
|
6 035
|
7 798
|
8 860
|
7 316
|
5 721
|
|
| Accrued Liabilities |
10 076
|
10 223
|
10 794
|
11 327
|
11 546
|
11 597
|
14 862
|
18 142
|
17 230
|
17 284
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1 118
|
971
|
1 126
|
1 124
|
129
|
|
| Other Current Liabilities |
5 177
|
9 150
|
8 686
|
10 093
|
15 383
|
16 543
|
25 875
|
44 338
|
40 536
|
37 527
|
|
| Total Current Liabilities |
20 727
|
24 981
|
25 011
|
26 104
|
32 647
|
35 293
|
49 506
|
72 466
|
66 207
|
60 660
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
4 166
|
3 241
|
2 144
|
0
|
|
| Deferred Income Tax |
308
|
133
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
272
|
252
|
220
|
168
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
5 744
|
7 258
|
8 685
|
7 104
|
12 839
|
15 876
|
15 338
|
4 233
|
2 479
|
3 287
|
|
| Total Liabilities |
27 051
N/A
|
32 624
+21%
|
33 916
+4%
|
33 376
-2%
|
45 486
+36%
|
51 169
+12%
|
69 010
+35%
|
79 941
+16%
|
70 829
-11%
|
63 947
-10%
|
|
| Equity | |||||||||||
| Common Stock |
11 090
|
11 090
|
11 090
|
11 090
|
11 090
|
11 090
|
11 090
|
11 090
|
11 090
|
11 090
|
|
| Retained Earnings |
302 535
|
327 529
|
352 074
|
372 615
|
398 651
|
433 649
|
475 609
|
531 213
|
575 404
|
613 538
|
|
| Additional Paid In Capital |
5 399
|
5 399
|
5 399
|
5 399
|
5 399
|
5 399
|
5 399
|
5 399
|
5 399
|
5 399
|
|
| Unrealized Security Profit/Loss |
15 008
|
15 781
|
13 373
|
12 612
|
11 252
|
13 108
|
9 547
|
9 630
|
9 300
|
9 213
|
|
| Treasury Stock |
0
|
0
|
0
|
9 600
|
5 300
|
5 300
|
5 300
|
5 300
|
3 371
|
3 371
|
|
| Other Equity |
9 427
|
10 162
|
11 170
|
402
|
10 525
|
10 573
|
10 591
|
10 591
|
16 848
|
16 848
|
|
| Total Equity |
324 605
N/A
|
349 638
+8%
|
370 765
+6%
|
392 519
+6%
|
431 619
+10%
|
468 519
+9%
|
506 936
+8%
|
562 624
+11%
|
614 670
+9%
|
652 717
+6%
|
|
| Total Liabilities & Equity |
351 656
N/A
|
382 262
+9%
|
404 682
+6%
|
425 894
+5%
|
477 105
+12%
|
519 688
+9%
|
575 946
+11%
|
642 564
+12%
|
685 499
+7%
|
716 664
+5%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
11
|
11
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
